School of Food and Nutritional Sciences, Department of Medicine, University College Cork, Cork, Ireland.
Am J Clin Nutr. 2012 Jun;95(6):1350-6. doi: 10.3945/ajcn.111.031427. Epub 2012 May 2.
The relative potency of 25-hydroxyvitamin D3 to vitamin D3 needs to be better defined so that food-composition tables can better reflect the true vitamin D nutritive value of certain foods.
We performed a randomized, controlled intervention study in apparently healthy, free-living adults to investigate whether the intake of 25-hydroxyvitamin D3 is 5 times more potent in raising serum 25-hydroxyvitamin D [25(OH)D] during winter compared with an equivalent amount of vitamin D3.
A randomized, placebo-controlled, double-blind intervention study was conducted in adults aged ≥50 y (n = 56) who consumed a placebo, 20 μg vitamin D3, or 7 or 20 μg 25-hydroxyvitamin D3 daily throughout 10 wk of winter. Serum 25(OH)D was measured by using an enzyme-linked immunoassay, and serum albumin-corrected calcium (S-Ca) was assessed colorimetrically at the baseline, midpoint, and endpoint of the study.
The mean (±SD) increases (per microgram of vitamin D compound) in serum 25(OH)D concentrations over baseline after 10 wk of supplementation were 0.96 ± 0.62, 4.02 ± 1.27, and 4.77 ± 1.04 nmol · L(-1) · μg intake(-1) for the 20-μg vitamin D3/d and 7- and 20-μg 25-hydroxyvitamin D3/d groups, respectively. A comparison of the 7- and 20-μg 25-hydroxyvitamin D3/d groups with the 20-μg vitamin D3/d group yielded conversion factors of 4.2 and 5, respectively. There was no effect of treatment on S-Ca concentrations and no incidence of hypercalcemia (S-Ca >2.6 nmol/L).
Each microgram of orally consumed 25-hydroxyvitamin D3 was about 5 times more effective in raising serum 25(OH)D in older adults in winter than an equivalent amount of vitamin D3. This conversion factor could be used in food-compositional tables for relevant foods. This study was registered at clinicaltrials.gov as NCT01398202.
为了使食物成分表更好地反映某些食物中真正的维生素 D 营养价值,需要更好地定义 25-羟维生素 D3 与维生素 D3 的相对效力。
我们进行了一项随机对照干预研究,以调查在冬季,与摄入等剂量的维生素 D3 相比,25-羟维生素 D3 的摄入量是否能使血清 25-羟维生素 D [25(OH)D]升高 5 倍,从而提高血清 25-羟维生素 D3 的相对效力。
我们对 56 名年龄≥50 岁的成年人进行了一项随机、安慰剂对照、双盲干预研究,这些成年人在整个冬季的 10 周内每天摄入安慰剂、20 μg 维生素 D3 或 7 或 20 μg 25-羟维生素 D3。使用酶联免疫吸附试验测量血清 25(OH)D,在研究的基线、中点和终点使用比色法评估血清白蛋白校正钙(S-Ca)。
10 周补充后,与基线相比,血清 25(OH)D 浓度的平均(±SD)升高量(每微克维生素 D 化合物)分别为 0.96±0.62、4.02±1.27 和 4.77±1.04 nmol·L(-1)·μg 摄入量(-1),分别为 20μg 维生素 D3/d、7μg 和 20μg 25-羟维生素 D3/d 组。与 20μg 维生素 D3/d 组相比,7μg 和 20μg 25-羟维生素 D3/d 组的转化率分别为 4.2 和 5。治疗对 S-Ca 浓度没有影响,也没有发生高钙血症(S-Ca>2.6 nmol/L)。
在冬季,与摄入等剂量的维生素 D3 相比,口服摄入的每微克 25-羟维生素 D3 使老年人血清 25(OH)D 升高约 5 倍。该转换因子可用于相关食物的食物成分表。本研究在 clinicaltrials.gov 注册,编号为 NCT01398202。